From: Isolated ACTH deficiency following immunization with the BNT162b2 SARS-CoV-2 vaccine: a case report
Reference range | Reference range | ||||
---|---|---|---|---|---|
RBC (10^4/μL) | 411 | 386–492 | TSH (μU/mL) | 8.470 | 0.61–4.23 |
WBC (10^4/μL) | 69 | 33–86 | Free-T3 (pg/mL) | 2.49 | 2.30–4.00 |
Neutro (%) | 54.9 | Free-T4 (ng/dL) | 1.22 | 0.90–1.70 | |
Lymph (%) | 34.1 | Anti-TPO Ab (IU/mL) | < 3 | 0.0–2.9 | |
Eosin (%) | 1.4 | Anti-Tg Ab (IU/mL) | < 5 | 0.0–4.9 | |
PLT (10^4/μL) | 15.6 | 15.8–34.8 | Anti-TR Ab (IU/L) | < 0.9 | < 2.0 |
Albumin (g/dL) | 4.6 | 4.1–5.1 | Prolactin (ng/mL) | 21.4 | |
Creatinine (mg/dL) | 0.60 | 0.65–1.07 | ACTH (pg/mL) | 6.9 | 8.7–61.5 |
eGFR (ml/min/1.73m2) | 126.6 | Cortisol (μg/dL) | 1.6 | ||
Sodium (mmol/L) | 114.4 | 138–145 | GH (ng/mL) | 0.1 | |
Potassium (mmol/L) | 3.6 | 3.6–4.8 | IGF-1(ng/mL) | 128 | 107–297 |
Chloride (mmol/L) | 84.3 | 101–108 | LH (mIU/mL) | 3.8 | |
Blood glucose (mg/dL) | 39 | 73–109 | FSH (mIU/mL) | 2.9 | |
IRI (μU/mL) | < 0.2 | 2.1–19.0 | ADH (pg/mL) | 1.2 | |
CPR (ng/mL) | 0.1 | 0.74–3.18 | |||
AST (U/L) | 87 | 13–30 | |||
ALT (U/L) | 28 | 7–23 | |||
LD_IFCC (U/L) | 343 | 124–222 | |||
γ-GTP (U/L) | 10 | 9–32 |